UPSA

UPSA is a French pharmaceutical laboratory that makes self-medication products, including over-the-counter medicines, dietary supplements and medical devices. Its website lists therapeutic areas such as pain and fever, ENT, sleep, digestion, women's health and vitality. Its best-known products are effervescent tablets, and it manufactures its medicines at its site in Agen, Lot-et-Garonne.

The company sells to patients and pharmacists, and its revenue comes from product sales. The website states that it exports to more than 60 countries. It is a subsidiary of Taisho Pharmaceutical Co. Ltd. of Japan, which acquired it in 2019; Bristol-Myers Squibb had owned it since 1994.

UPSA was founded in 1935, with origins traced to the early 1920s in Agen. The website states that it is B Corp certified and uses the Agen and Rueil-Malmaison locations for its open roles. Current openings cover production, quality, formulation and R&D, industrial excellence, regulatory affairs, marketing, and a digital transformation apprenticeship.

Product: Over-the-counter medicines (pain and fever, ENT, sleep, digestion, women's health), dietary supplements and medical devices.